Merit Capital Stock vs Total Liab Analysis

MMSI Stock

USD 105.33 0.30 0.29%

Merit Medical financial indicator trend analysis is infinitely more than just investigating Merit Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merit Medical Systems is a good investment. Please check the relationship between Merit Medical Capital Stock and its Total Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Capital Stock vs Total Liab

Capital Stock vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merit Medical Systems Capital Stock account and Total Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between Merit Medical's Capital Stock and Total Liab is 0.67. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Total Liab in the same time period over historical financial statements of Merit Medical Systems, assuming nothing else is changed. The correlation between historical values of Merit Medical's Capital Stock and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Merit Medical Systems are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Capital Stock i.e., Merit Medical's Capital Stock and Total Liab go up and down completely randomly.

Correlation Coefficient

0.67

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Merit Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

As of now, Merit Medical's Enterprise Value is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	406.9M	418.0M	459.9M	482.9M
Cost Of Revenue	589.4M	631.9M	673.5M	707.2M

Total Operating Expenses Cost Of Revenue

Merit Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Cash	Cash And Short Term Investments	Accounts Payable	Non Currrent Assets Other	Common Stock Total Equity	Common Stock
Total Assets		0.9	0.93	0.93	0.98	0.93	0.72	0.96	0.95	0.98	0.69	0.93	0.99	0.86	-0.34	0.97	0.94	0.93	0.53	0.87	0.74	0.74	0.95	0.79	0.98	0.94
Short Long Term Debt Total	0.9		0.72	0.71	0.8	0.75	0.67	0.87	0.77	0.8	0.44	0.99	0.85	0.76	-0.33	0.97	0.82	0.95	0.15	0.68	0.9	0.9	0.78	0.63	0.81	0.72
Other Current Liab	0.93	0.72		0.99	0.96	0.92	0.64	0.88	0.94	0.97	0.73	0.76	0.94	0.79	-0.35	0.85	0.91	0.79	0.7	0.87	0.55	0.55	0.92	0.76	0.96	0.97
Total Current Liabilities	0.93	0.71	0.99		0.98	0.95	0.66	0.9	0.96	0.98	0.78	0.75	0.95	0.83	-0.37	0.84	0.92	0.78	0.75	0.87	0.52	0.52	0.95	0.77	0.97	0.98
Total Stockholder Equity	0.98	0.8	0.96	0.98		0.95	0.66	0.96	0.96	0.99	0.76	0.83	0.99	0.88	-0.3	0.9	0.95	0.87	0.67	0.87	0.64	0.64	0.97	0.8	0.99	0.98
Property Plant And Equipment Net	0.93	0.75	0.92	0.95	0.95		0.78	0.91	0.97	0.96	0.84	0.79	0.93	0.84	-0.33	0.86	0.9	0.76	0.72	0.85	0.5	0.5	0.94	0.71	0.92	0.93
Net Debt	0.72	0.67	0.64	0.66	0.66	0.78		0.62	0.83	0.72	0.7	0.73	0.64	0.5	-0.52	0.75	0.52	0.49	0.46	0.83	0.27	0.27	0.66	0.65	0.62	0.65
Retained Earnings	0.96	0.87	0.88	0.9	0.96	0.91	0.62		0.89	0.94	0.7	0.87	0.98	0.95	-0.28	0.92	0.96	0.93	0.49	0.74	0.75	0.75	0.95	0.75	0.93	0.89
Non Current Assets Total	0.95	0.77	0.94	0.96	0.96	0.97	0.83	0.89		0.98	0.82	0.82	0.93	0.78	-0.39	0.89	0.85	0.76	0.71	0.95	0.5	0.5	0.94	0.83	0.94	0.96
Net Receivables	0.98	0.8	0.97	0.98	0.99	0.96	0.72	0.94	0.98		0.78	0.83	0.98	0.85	-0.36	0.9	0.93	0.84	0.68	0.89	0.6	0.6	0.96	0.81	0.98	0.98
Common Stock Shares Outstanding	0.69	0.44	0.73	0.78	0.76	0.84	0.7	0.7	0.82	0.78		0.5	0.7	0.65	-0.21	0.58	0.64	0.45	0.77	0.74	0.16	0.16	0.78	0.68	0.69	0.75
Non Current Liabilities Total	0.93	0.99	0.76	0.75	0.83	0.79	0.73	0.87	0.82	0.83	0.5		0.87	0.75	-0.34	0.99	0.81	0.93	0.22	0.76	0.85	0.85	0.8	0.69	0.85	0.77
Inventory	0.99	0.85	0.94	0.95	0.99	0.93	0.64	0.98	0.93	0.98	0.7	0.87		0.9	-0.31	0.93	0.96	0.92	0.56	0.83	0.72	0.72	0.97	0.77	0.98	0.95
Other Current Assets	0.86	0.76	0.79	0.83	0.88	0.84	0.5	0.95	0.78	0.85	0.65	0.75	0.9		-0.31	0.8	0.93	0.85	0.48	0.59	0.69	0.69	0.9	0.65	0.83	0.79
Other Stockholder Equity	-0.34	-0.33	-0.35	-0.37	-0.3	-0.33	-0.52	-0.28	-0.39	-0.36	-0.21	-0.34	-0.31	-0.31		-0.36	-0.29	-0.23	-0.24	-0.36	-0.12	-0.12	-0.32	-0.33	-0.29	-0.3
Total Liab	0.97	0.97	0.85	0.84	0.9	0.86	0.75	0.92	0.89	0.9	0.58	0.99	0.93	0.8	-0.36		0.87	0.94	0.35	0.82	0.82	0.82	0.87	0.74	0.91	0.85
Property Plant And Equipment Gross	0.94	0.82	0.91	0.92	0.95	0.9	0.52	0.96	0.85	0.93	0.64	0.81	0.96	0.93	-0.29	0.87		0.92	0.52	0.69	0.75	0.75	0.94	0.62	0.94	0.9
Total Current Assets	0.93	0.95	0.79	0.78	0.87	0.76	0.49	0.93	0.76	0.84	0.45	0.93	0.92	0.85	-0.23	0.94	0.92		0.24	0.65	0.94	0.94	0.84	0.64	0.89	0.8
Short Term Debt	0.53	0.15	0.7	0.75	0.67	0.72	0.46	0.49	0.71	0.68	0.77	0.22	0.56	0.48	-0.24	0.35	0.52	0.24		0.67	-0.09	-0.09	0.63	0.56	0.63	0.74
Intangible Assets	0.87	0.68	0.87	0.87	0.87	0.85	0.83	0.74	0.95	0.89	0.74	0.76	0.83	0.59	-0.36	0.82	0.69	0.65	0.67		0.39	0.39	0.82	0.87	0.87	0.9
Cash	0.74	0.9	0.55	0.52	0.64	0.5	0.27	0.75	0.5	0.6	0.16	0.85	0.72	0.69	-0.12	0.82	0.75	0.94	-0.09	0.39		1.0	0.61	0.43	0.68	0.55
Cash And Short Term Investments	0.74	0.9	0.55	0.52	0.64	0.5	0.27	0.75	0.5	0.6	0.16	0.85	0.72	0.69	-0.12	0.82	0.75	0.94	-0.09	0.39	1.0		0.61	0.43	0.68	0.55
Accounts Payable	0.95	0.78	0.92	0.95	0.97	0.94	0.66	0.95	0.94	0.96	0.78	0.8	0.97	0.9	-0.32	0.87	0.94	0.84	0.63	0.82	0.61	0.61		0.77	0.95	0.94
Non Currrent Assets Other	0.79	0.63	0.76	0.77	0.8	0.71	0.65	0.75	0.83	0.81	0.68	0.69	0.77	0.65	-0.33	0.74	0.62	0.64	0.56	0.87	0.43	0.43	0.77		0.77	0.79
Common Stock Total Equity	0.98	0.81	0.96	0.97	0.99	0.92	0.62	0.93	0.94	0.98	0.69	0.85	0.98	0.83	-0.29	0.91	0.94	0.89	0.63	0.87	0.68	0.68	0.95	0.77		0.99
Common Stock	0.94	0.72	0.97	0.98	0.98	0.93	0.65	0.89	0.96	0.98	0.75	0.77	0.95	0.79	-0.3	0.85	0.9	0.8	0.74	0.9	0.55	0.55	0.94	0.79	0.99

Click cells to compare fundamentals

Merit Medical Account Relationship Matchups

Merit Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	1.7B	1.6B	1.7B	2.3B	2.4B
Short Long Term Debt Total	523.7M	435.1M	315.0M	268.8M	891.4M	935.9M
Other Current Liab	108.0M	99.0M	148.3M	112.2M	120.4M	126.5M
Total Current Liabilities	181.7M	185.0M	236.3M	220.6M	203.6M	213.7M
Total Stockholder Equity	949.9M	958.6M	1.0B	1.1B	1.2B	1.3B
Property Plant And Equipment Net	459.0M	461.0M	437.6M	448.2M	446.6M	468.9M
Net Debt	479.4M	378.2M	247.3M	210.3M	302.2M	317.3M
Retained Earnings	368.2M	357.8M	406.3M	480.8M	575.2M	603.9M
Non Current Assets Total	1.3B	1.2B	1.2B	1.1B	1.2B	1.3B
Net Receivables	168.5M	158.0M	172.8M	178.4M	189.3M	198.7M
Common Stock Shares Outstanding	56.2M	55.4M	57.4M	57.7M	58.4M	39.5M
Liabilities And Stockholders Equity	1.8B	1.7B	1.6B	1.7B	2.3B	2.4B
Non Current Liabilities Total	625.7M	520.8M	372.2M	298.9M	919.7M	965.7M
Inventory	225.7M	198.0M	221.9M	266.0M	303.9M	319.1M
Other Current Assets	12.5M	16.8M	19.7M	26.2M	26.2M	27.5M
Other Stockholder Equity	(294K)	(5.5M)	(8.0M)	(11.6M)	(1.0)	(0.95)
Total Liab	807.4M	705.8M	608.5M	519.6M	1.1B	1.2B
Property Plant And Equipment Gross	459.0M	461.0M	652.3M	686.2M	775.6M	814.4M
Total Current Assets	454.5M	429.7M	482.2M	529.1M	1.1B	1.2B
Accumulated Other Comprehensive Income	(5.3M)	(5.5M)	(8.0M)	(11.6M)	(11.3M)	(10.8M)
Short Term Debt	19.1M	33.3M	29.8M	33.3M	12.1M	10.5M
Intangible Assets	445.3M	367.9M	319.3M	275.9M	325.9M	342.2M
Cash	44.3M	56.9M	67.8M	58.4M	589.1M	618.6M
Cash And Short Term Investments	44.3M	56.9M	67.8M	58.4M	589.1M	618.6M
Accounts Payable	54.6M	49.8M	55.6M	68.5M	65.9M	69.2M
Non Currrent Assets Other	24.3M	25.6M	26.7M	28.8M	32.3M	33.9M
Common Stock Total Equity	587.0M	606.2M	641.5M	675.2M	776.5M	815.3M
Common Stock	587.0M	606.2M	641.5M	675.2M	638.2M	670.1M
Other Liab	120.7M	102.7M	76.3M	52.4M	60.3M	35.4M
Other Assets	28.1M	227.7M	47.5M	31.9M	36.7M	25.7M
Long Term Debt	432.0M	343.7M	234.4M	186.8M	823.0M	864.2M
Good Will	353.2M	363.5M	361.7M	359.8M	382.2M	401.4M
Property Plant Equipment	459.0M	382.7M	437.6M	383.0M	440.4M	462.4M
Net Tangible Assets	151.4M	227.1M	358.8M	508.7M	585.0M	614.3M
Long Term Debt Total	432.0M	343.7M	234.4M	186.8M	214.8M	281.4M
Long Term Investments	17.1M	12.0M	14.7M	15.6M	19.1M	12.1M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:

How To Invest In Merit

Details

Is Merit Stock a good investment?

Details

What is Merit Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.091

Earnings Share

2.05

Revenue Per Share

22.847

Quarterly Revenue Growth

0.078

Return On Assets

0.0456

The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Merit Capital Stock vs Total Liab Analysis

Capital Stock vs Total Liab

Capital Stock vs Total Liab Correlation Analysis

Correlation Coefficient

Capital Stock

Total Liab

Merit Medical fundamental ratios Correlations

Merit Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Merit Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Other Current Liab
Net Receivables	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.52	Net Debt
Other Stockholder Equity	- 0.39	Non Current Assets Total
Other Stockholder Equity	- 0.37	Total Current Liabilities
Intangible Assets	- 0.36	Other Stockholder Equity
Total Liab	- 0.36	Other Stockholder Equity
Other Stockholder Equity	- 0.36	Net Receivables